2 highly rated ASX dividend shares to buy now

Wesfarmers Ltd (ASX:WES) and this buy-rated ASX dividend share could be great options for income investors right now. Here’s why…
The post 2 highly rated ASX dividend shares to buy now appeared first on The Motley Fool Australia. –

ASX dividend shares represented by cash in jeans back pocket

Luckily in this low interest rate environment, the Australian share market has plenty of options for investors looking to generate a passive income.

But which ASX dividend shares should you buy today? Here are two that come highly rated:

Integral Diagnostics Ltd (ASX: IDX)

The first ASX dividend share to look at is this medical imaging service provider. At present, Integral Diagnostics operates from a total of 72 radiology clinics, including 26 comprehensive sites. From these sites, the company employs some of the region’s leading radiologists and nuclear medicine specialists.

During the first half of FY 2021, the company reported a 29.5% increase in revenue to $170.7 million and a 61.1% jump in net profit after tax to $23.2 million.

This went down well with analysts at Goldman Sachs. In response to the release, the broker initiated coverage on the company with a buy rating and $5.50 price target.

In addition to this, based on the latest Integral Diagnostics share price, it estimates that its shares offer a fully franked 2.5% dividend yield. While this is not the biggest yield you’ll find, the broker believes it can grow at a solid rate in the coming years.

Goldman notes that Integral Diagnostics is “a well-run business in an attractive industry, with a relatively secure volume profile of mid/high single digit growth, and a clear path for further growth through brownfield and M&A activities.”

Wesfarmers Ltd (ASX: WES)

Another dividend share to consider is Wesfarmers. Like Integral Diagnostics, this conglomerate was on form during the first half of FY 2021.

For the six months ended 31 December, Wesfarmers reported a 16.6% increase in revenue to $17,774 million and a 25.5% increase in net profit after tax to $1,414 million.

While this was driven by solid sales growth across much of the company, its key Bunnings business was clearly the star of the show. The hardware giant recorded a 24.4% increase in revenue to $9,054 million.

Goldman Sachs was pleased with this result as well. In response to it, the broker put a buy rating and $59.70 price target on its shares.

Looking ahead, Goldman is forecasting a fully franked FY 2021 dividend of $1.88 per share. Based on the latest Wesfarmers share price, this equates to an attractive 3.8% yield.

These Dividend Stocks Could Be Your Next Cash Kings (FREE REPORT)

Motley Fool Australia’s Dividend experts recently released a brand-new FREE report revealing 3 dividend stocks with JUICY franked dividends that could keep paying you meaty dividends for years to come.

Our team of investors think these 3 dividend stocks should be a ‘must consider’ for any savvy dividend investor. But more importantly, could potentially make Australian investors a heap of passive income.

Don’t miss out! Simply click the link below to grab your free copy and discover these 3 high conviction stocks now.

Click Here For Your Free Stock Report

Returns As of 15th February 2021

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Wesfarmers Limited. The Motley Fool Australia has recommended Integral Diagnostics Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 highly rated ASX dividend shares to buy now appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!